Physician profile
Iris Kaushik
NPI 1194102871
$385.67
in general payments reported to CMS, 2019-2025
17 companies · $102 in 2025
The $102 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.43 · 2022: $19.17 · 2023: $76.96 · 2024: $130 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $57.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $38.18 | 2024 | |
| Sanofi Pasteur INC. | $28.38 | 2024 | |
| Pfizer INC. | $27.70 | 2025 | |
| Nestle Healthcare Nutrition INC. | $26.02 | 2023 | |
| Kyowa Kirin, INC. | $25.18 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.35 | 2023 | Elaprase |
| Kaleo, INC. | $19.17 | 2022 | |
| Glaxosmithkline, LLC. | $18.39 | 2023 | Pediarix, Rotarix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $18.32 | 2024 | Flumist Quadrivalent |
| Cipher Pharmaceuticals US LLC | $17.98 | 2025 | Spinosad, Natroba |
| Merck Sharp & Dohme LLC | $16.83 | 2025 | Capvaxive, Gardasil 9 |
| Tris Pharma INC | $15.57 | 2024 | Onyda Xr |
| Cumberland Pharmaceuticals, INC. | $15.55 | 2024 | Kristalose |
| Kowa Pharmaceuticals America, INC. | $14.57 | 2025 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $13.85 | 2024 | Azstarys |
| Cranial Technologies, INC | $13.20 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Kaushik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.